Effects | HBV/HCV | HCV | Effect size | Heterogeneity | |||||
---|---|---|---|---|---|---|---|---|---|
 | Studies (n) | Sample size | Events | Sample size | Events | OR(95% CI) | P | I 2 | P |
ETVR | 4 | 271 | 233 | 308 | 266 | 1.03(0.37-2.82) | 0.96 | 69% | 0.02 |
SVR | 5 | 313 | 213 | 392 | 276 | 0.87(0.62-1.21) | 0.38 | 0% | 0.61 |
HCV relapse | 4 | 270 | 49 | 308 | 42 | 1.55(0.98-2.47) | 0.06 | 47% | 0.13 |
HCV genotype 1 relapse | 2 | 127 | 27 | 135 | 13 | 2.4(1.17-4.91) | 0.19 | 74% | 0.05 |
HCV non-genotype 1 relapse | 2 | 84 | 7 | 71 | 7 | 0.9(0.3-2.71) | 0.85 | 0% | 0.4o |